Cardiorenal outcomes with ertugliflozin by baseline glucose-lowering agent: an analysis from VERTIS CV Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Charbonnel, B.; Dagogo-Jack, S.; Cannon, C. P.; Cherney, D. Z. I.; Cosentino, F.; McGuire, D. K.; Shih, W. J.; Liu, J.; Pong, A.; Gantz, I.; Frederich, R.; Mancuso, J. P.; Pratley, R. E.

authors

Publication Date

  • September 1, 2021

webpage

published in

category

start page

  • 226

end page

  • 226

volume

  • 64

issue

  • SUPPL 1